EPISEEK™

A Revolutionary Epigenetic-Based, Early Cancer Detection Tool

Unlock the life-saving power of epigenetics with PRECISION EPIGENOMICS early ​cancer detection tool! EPISEEK is able to identify more than 20 prevalent cancer types - many of which have no other early detection ​test available.
PLACE PATIENT ORDERS*
I am a Healthcare Provider
TruDiagnostic.com Precision Epigenomics Test Kit EPISEEK

*EPISEEK analysis is only available through TruDiagnostic to registered healthcare provider partners.
You can sign up for a free clinician account
here, to place patient orders and access results through our provider portal

Detecting the ​Undetectable

When it comes to cancer, early detection is key to saving ​lives! With 610,000+ cancer deaths in the U.S. each year, most of which stemming from cancer types with no FDA-approved screening options, EPISEEK is making revolutionary ​strides in detecting cancers that have been previously ​undetectable in early stages.

The EPISEEK liquid biopsy blood test is intended to be ​used as a complementary tool to established cancer ​screening assessments. However in some cases, especially ​for cancer types that have no previously established ​screening test and are notoriously hard to detect, it may ​be the only warning sign currently available for ​providers.

TruDiagnostic.com EPISEEK - Precision Epigenomics - Detecting the Undetectable
57% of all diagnosed cancers currently do not have a recommended screening test (and account for 70% of all cancer-related deaths)
86 % of cancer cases are not diagnosed after a patient had a recommended screening test (one of only four that have a government-recommended, early detection tool available)
16M+
life years saved in the U.S. from early-detection screenings.
TruDiagnostic.com EPISEEK - Precision Epigenomics - Advancing Screening Accuracy

Advancing Screening Accuracy

Recent research from the University of Chicago shows that only 14% of cancers in the U.S. are diagnosed after the patient had a recommended screening test. This further highlights the value of a complementary tool like EPISEEK, that has higher sensitivity and specificity outputs.

COMPARE DETECTION ASSAYS
TruDiagnostic.com EPISEEK - Precision Epigenomics - Detects more than 20 ​cancer types
Detects more than 20 ​cancer types
TruDiagnostic.com EPISEEK - Precision Epigenomics - Peer reviewed manuscripts: 5
Peer reviewed
manuscripts: 5
TruDiagnostic.com EPISEEK - Precision Epigenomics - Scientific meeting ​abstracts: 6
Scientific meeting ​abstracts: 6
TruDiagnostic.com EPISEEK - Precision Epigenomics - Liquid Biopsy
EPISEEK logo
Galleri logo
One Test logo
Technology
CpG cfDNA qPCR
CpG cfDNA NGS
Cancer Ag’s, AI
Turn Around time
(TAT) *
5 days
10 days
10 days
Lung
(sensitivity / specificity)
80% / >98%
75% / >99%
75% / >80%
Breast
(sensitivity / specificity)
54% / >98%
31% / >99%
81% / >80%
Pancreatic
(sensitivity / specificity)
93% / >98%
84% / >99%
89% / >80%
Cost / Test
*Pricing is determined by your healthcare provider

Who Can Order EPISEEK?

Ordering and Logistics

01.
Ordering Your Kit
Test kits can be ordered through the TruDiagnostic provider portal. Immediately before a sample is collected, the kit must be registered to a particular patient through the TruDiagnostic portal.
02.
Specimen Requirements
A peripheral whole blood specimen, submitted in the two Streck Cell-Free DNA tubes (10 ml each) which are provided in the collection kit, is needed for analysis. The patient need not be fasting. Because the laboratory intends to process the specimen the day after collection, specimens should be collected and submitted only on days which precede workdays (typically Monday through Thursday, excluding holiday weekends). Specimens must not freeze, and they should be stored and transported at 37-87°F.

A specimen will be rejected if it is: submitted in blood collection tubes other than the provided Streck Cell-Free DNA tubes, submitted in expired collection tubes, less than 10 ml total, not properly labeled with two unique identifiers or is illegible, hemolyzed or clotted, not received within 48 hours of collection, or not accompanied by a registered kit with complete order.
03.
Storing Kits
The supplied kits with their contents may be stored at room temperature. The Streck tube lot and expiration date are printed on the box exterior for easy kit management.
04.
Results Ready
In most cases, the test results are available within 1 week from arrival in our laboratory. Once ready, results can be accessed and viewed on TruDiagnostic’s provider portal.
01.
Ordering Your Kit
Test kits can be ordered through the TruDiagnostic provider portal. Immediately before a sample is collected, the kit must be registered to a particular patient through the TruDiagnostic portal.
02.
Specimen Requirements
A peripheral whole blood specimen, submitted in the two Streck Cell-Free DNA tubes (10 ml each) which are provided in the collection kit, is needed for analysis. The patient need not be fasting. Because the laboratory intends to process the specimen the day after collection, specimens should be collected and submitted only on days which precede workdays (typically Monday through Thursday, excluding holiday weekends). Specimens must not freeze, and they should be stored and transported at 37-87°F.
A specimen will be rejected if it is: submitted in blood collection tubes other than the provided Streck Cell-Free DNA tubes, submitted in expired collection tubes, less than 10 ml total, not properly labeled with two unique identifiers or is illegible, hemolyzed or clotted, not received within 48 hours of collection, or not accompanied by a registered kit with complete order.
03.
Storing Kits
The supplied kits with their contents may be stored at room temperature. The Streck tube lot and expiration date are printed on the box exterior for easy kit management.
04.
Results Ready
In most cases, the test results are available within 1 week from arrival in our laboratory. Once ready, results can be accessed and viewed on TruDiagnostic’s provider portal.

FAQ

Explore our FAQs to discover the science behind EPISEEK and how it's transforming the way we ​approach cancer diagnosis.

WHAT IS EPISEEK?
WHICH CANCERS SHOULD
EPISEEK DETECT?
WHICH CANCERS SHOULD EPISEEK DETECT?
WHAT ABOUT FALSE POSITIVES?
DOES EPISEEK PREDICT MY RISK OF DEVELOPING CANCER?
DOES EPISEEK PREDICT MY RISK OF
DEVELOPING CANCER?
WHICH PATIENTS CAN TAKE EPISEEK?
WHY ARE CONVENTIONAL RECOMMENDATIONS FOR CANCER SCREENING STILL
APPROPRIATE IF a PATIENT TAKES EPISEEK?
WHY ARE CONVENTIONAL RECOMMENDATIONS
FOR CANCER SCREENING STILL
APPROPRIATE IF a PATIENT TAKES EPISEEK?
WHO CAN ORDER EPISEEK?
IS EPISEEK RECOMMENDED IN
CANCER SCREENING GUIDELINES?
IS EPISEEK RECOMMENDED IN CANCER SCREENING GUIDELINES?
WHAT IS THE RECOMMENDED
SCREENING INTERVAL FOR EPISEEK?
WHAT IS THE RECOMMENDED SCREENING INTERVAL FOR EPISEEK?
WHERE IS THE TEST
CURRENTLY AVAILABLE?
WHERE IS THE TEST CURRENTLY AVAILABLE?
HOW MUCH DOES EPISEEK TESTING COST?
CAN PATIENTS USE THEIR HSA OR FSA TO PAY
FOR THE TEST?
CAN PATIENTS USE THEIR HSA OR FSA TO PAY FOR THE TEST?
HOW CAN A LICENSED HEALTHCARE PROVIDER
ORDER EPISEEK FOR THEIR PATIENT?
HOW CAN A LICENSED HEALTHCARE PROVIDER ORDER EPISEEK FOR THEIR PATIENT?
WHAT ARE THE SPECIMEN REQUIREMENTS
FOR EPISEEK?
WHAT ARE THE SPECIMEN REQUIREMENTS FOR EPISEEK?
HOW SHOULD THE COLLECTION KITS BE STORED?
DO PATIENTS NEED TO FAST OR OTHERWISE
PREPARE FOR THIS TEST?
DO PATIENTS NEED TO FAST OR OTHERWISE PREPARE FOR THIS TEST?
WHEN WILL MY PATIENT’S TEST RESULTS BE READY?
HOW WILL I RECEIVE THE TEST RESULTS?
WHAT DOES “CANCER SIGNAL NOT DETECTED”
MEAN?
WHAT DOES “CANCER SIGNAL NOT DETECTED” MEAN?
WHAT DOES “INDETERMINATE SIGNAL DETECTED”
MEAN?
WHAT DOES “INDETERMINATE SIGNAL DETECTED” MEAN?
WHAT DOES “ABNORMAL SIGNAL DETECTED”
MEAN, AND WHY DOES IT NEED TO BE CONFIRMED
WITH DIAGNOSTIC TESTING?
WHAT DOES “ABNORMAL SIGNAL DETECTED” MEAN, AND WHY DOES IT NEED TO BE CONFIRMED
WITH DIAGNOSTIC TESTING?
WHAT DIAGNOSTIC TESTS SHOULD BE ORDERED TO
CONFIRM A DIAGNOSIS FOR AN
“ABNORMAL SIGNAL DETECTED” RESULT?
WHAT DIAGNOSTIC TESTS SHOULD BE ORDERED TO CONFIRM A DIAGNOSIS FOR AN
“ABNORMAL SIGNAL DETECTED” RESULT?
WHAT IF THE DIAGNOSTIC WORKUP sHOWS NO
SIGN OF CANCER FOR A PATIENT WITH A
“ABNORMAL SIGNAL DETECTED” RESULT?
WHAT IF THE DIAGNOSTIC WORKUP sHOWS NO SIGN OF CANCER FOR A PATIENT WITH A
“ABNORMAL SIGNAL DETECTED” RESULT?
WHAT DO I DO IF I RECEIVE A “CANCELED”
TEST RESULT?
What do I do if I receive a “CANCELED RESULT”?
WHERE CAN I FIND MORE INFORMATION ON THE
TEST AND PATIENT INFORMED CONSENT?
WHERE CAN I FIND MORE INFORMATION ON THE TEST AND PATIENT INFORMED CONSENT?